
Exploring the complex human brain through innovative patient-centric discoveries in neuroscience, including the repurposing of a vaccine, halting disease progression at the genetic level, and digital therapeutics.
Exploring the complex human brain through innovative patient-centric discoveries in neuroscience, including the repurposing of a vaccine, halting disease progression at the genetic level, and digital therapeutics.
Contract Research Organizations (CROs) are clinical research providers engaged by sponsors to manage various aspects of clinical trials.
Neus Valveny, Senior Director, Head of RWE at TFS, shares insights, experiences, and thoughts on diversity within the life sciences industry.
Explore Functional Service Providers (FSP) in clinical research, focusing on their role, benefits, evolution, and impact on the industry.
Discover the top 10 oncology CROs making significant strides in cancer research and drug development in 2024.
Explore how TFS HealthScience drives gender diversity in leadership, fostering innovation and business growth while challenging industry norms.
Hanna Sandvall, MSc, VP of Strategic Resource Solutions at TFS, shares leadership insights and championing equality in science and research.
This article explores the journey of women leaders in life sciences, focusing on challenges, achievements, and insights from TFS, celebrating International Women’s Day 2024.
Explore employee experiences at the top CROs of 2024, highlighting their strengths and areas for improvement based on Glassdoor ratings and feedback.
Explore the pivotal role of a Contract Research Organization (CRO) in clinical research, their services, and impact on the industry.
Noelia Ortega, BU Head of Strategic Resourcing Solutions at TFS, shares leadership insights and the impact of inspiring women on her career.
Discover the challenges inflammatory diseases CROs face during clinical trials and how they use innovative solutions to address them.
Marcia Swank, VP of Ophthalmology at TFS, shares insights on leadership, diversity, and fostering inclusive innovation in life sciences.
Ophthalmology research and ocular drug development have made ground-breaking discoveries to fuel its growth further in 2024.
Bin Pan, TFS’s Executive Director of Program Strategy, discusses defining moments in her career, gender diversity, and female empowerment.